Document Detail


The kidney, hypertension, and remaining challenges.
MedLine Citation:
PMID:  19427500     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
There is an epidemic of chronic kidney disease in the Western world, with hypertension being the second most common cause. Blood pressure control rates, while improving, are still below 50% for the United States population. The following three challenges remain for the treatment of hypertension and associated prevention of end-stage kidney disease. First, a better understanding by the general medical community of how and in whom to use renin angiotensin aldosterone system blockers is needed. Second, the appropriate initiation of fixed-dose combination therapy to achieve blood-pressure goals needs to be clarified. Finally, the subgroup of patients with kidney disease needs more aggressive blood pressure lowering.
Authors:
Nitin Khosla; Rigas Kalaitzidis; George L Bakris
Publication Detail:
Type:  Journal Article; Review    
Journal Detail:
Title:  The Medical clinics of North America     Volume:  93     ISSN:  1557-9859     ISO Abbreviation:  Med. Clin. North Am.     Publication Date:  2009 May 
Date Detail:
Created Date:  2009-05-11     Completed Date:  2009-06-09     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  2985236R     Medline TA:  Med Clin North Am     Country:  United States    
Other Details:
Languages:  eng     Pagination:  697-715, Table of Contents     Citation Subset:  AIM; IM    
Affiliation:
Department of Medicine, Section of Nephrology and Hypertension, University of California at San Diego, San Diego, CA, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Antihypertensive Agents / pharmacology,  therapeutic use
Blood Pressure / drug effects
Humans
Hypertension, Renovascular / complications,  drug therapy*,  epidemiology
Kidney / drug effects*
Kidney Failure, Chronic / epidemiology,  etiology,  prevention & control*
Renin-Angiotensin System / drug effects
United States / epidemiology
Chemical
Reg. No./Substance:
0/Antihypertensive Agents

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Hypertension and myocardial ischemia.
Next Document:  Current approaches to renovascular hypertension.